ZBH

#609
Zimmer Biomet Holdings, Inc. Common Stock
100.4 2 USD
+0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
100.30
101.11
Intervallo Annuale
79.12
103.69
Variazione giornaliera
+1.02%
Variazione Mensile
+4.55%
Variazione di 6 mesi
+2.59%
Variazione Annuale
-2.98%
Chiusura Precedente
99.4 1
Open
101.0 7
Minimo
100.3 0
Massimo
101.1 1
Volume
199
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi Documents

2026

Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Current report, Q3 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
ZIMMER BIOMET HOLDINGS, INC. current report, Q1 FY2026
8-K

ZIMMER BIOMET HOLDINGS, INC. current report, Q2 FY2017

Full document

Business Context and Reporting Period

This Form 8-K reports on the annual meeting of stockholders held by Zimmer Biomet Holdings, Inc. on May 12, 2017. The filing details the outcomes of four proposals submitted to security holders regarding corporate governance and executive compensation.

Key Financial Metrics

This filing is a current report regarding corporate governance events and does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.

Material Changes and Voting Results

Stockholders approved all four proposals presented at the meeting. The specific vote tabulations are as follows:

  • Proposal 1 (Election of Directors): All 11 nominees were elected. While most received over 90% support, nominee Arthur J. Higgins received approximately 93.6% "For" votes, with 10,012,694 votes cast "Against."
  • Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for 2017. The proposal received 170,775,072 "For" votes versus 1,741,672 "Against" votes.
  • Proposal 3 (Say on Pay): Stockholders approved, on an advisory basis, the compensation of named executive officers. The vote was 144,554,233 "For" and 11,306,266 "Against."
  • Proposal 4 (Frequency of Say on Pay): Stockholders voted to hold future advisory votes on executive compensation on an annual basis. The "One Year" option received 139,964,763 votes, significantly outpacing the "Three Years" option (16,418,681 votes).

Guidance, Outlook, and Risks

The filing contains no management commentary on financial guidance, outlook, risks, contingencies, or unusual items. The Board of Directors has determined, based on the voting results of Proposal 4, that future Say on Pay votes will be held annually.

Key Facts for Investor Verification

  • Verify the full list of elected directors and their tenure terms ending at the 2018 annual meeting.
  • Confirm the appointment of PricewaterhouseCoopers LLP as the auditor for the 2017 fiscal year.
  • Note the significant "Against" vote count for director Arthur J. Higgins (approx. 10 million votes) compared to other nominees.
  • Confirm the company's commitment to annual "Say on Pay" votes as mandated by the shareholder advisory vote.

Notizie